Predicate |
Object |
contentType |
Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Review |
endingPage |
6908 |
issn |
1078-0432 1557-3265 |
issueIdentifier |
23 |
pageRange |
6899-6908 |
publicationName |
Clinical cancer research : an official journal of the American Association for Cancer Research |
startingPage |
6899 |
hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2f1f5a3920787349e896f76286119f3a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 |
isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_259ae0443f2d892d0931963c85da723b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b764b3554ad23ec90d3cff07f3e13505 |
bibliographicCitation |
Parseghian CM, Napolitano S, Loree JM, Kopetz S. Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies. Clin Cancer Res. 2019 Dec 01;25(23):6899–908. PMID: 31263029; PMCID: PMC6891150. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_191abe237df756edfb5f2bec40ac4508 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2047-097X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b6db2fed7a8bf30b4c2ee4ecb4e2693 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8189-2132 |
date |
2019-12-01^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC6891150 https://doi.org/10.1158/1078-0432.ccr-19-0823 https://pubmed.ncbi.nlm.nih.gov/31263029 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265 https://portal.issn.org/resource/ISSN/1078-0432 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies |
discusses |
http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M0457532 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D058990 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D019008Q000235 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D009369Q000235 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D066246Q000037 http://id.nlm.nih.gov/mesh/D066246Q000235 http://id.nlm.nih.gov/mesh/D009369Q000473 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce |